These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24393111)

  • 1. Physiological factors with impact on the drug behaviour in the gastrointestinal tract.
    Franc A; Dvořáčková K; Kejdušová M; Goněc R
    Ceska Slov Farm; 2013 Dec; 62(6):243-8. PubMed ID: 24393111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.
    Li Z; He X
    Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamic gastric environment and its impact on drug and formulation behaviour.
    Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotically controlled drug delivery system with associated drugs.
    Gupta BP; Thakur N; Jain NP; Banweer J; Jain S
    J Pharm Pharm Sci; 2010; 13(4):571-88. PubMed ID: 21486532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
    Koziolek M; Grimm M; Schneider F; Jedamzik P; Sager M; Kühn JP; Siegmund W; Weitschies W
    Adv Drug Deliv Rev; 2016 Jun; 101():75-88. PubMed ID: 27037063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive floating drug-delivery systems: a critical review.
    Kotreka UK; Adeyeye MC
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):47-99. PubMed ID: 21395515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of oral drug formulations and methods for its improvement].
    Ipatova OM; Torkhovskaia TI; Medvedeva NV; Prozorovskiĭ VN; Ivanova ND; Shironin AV; Baranova VS; Archakov AI
    Biomed Khim; 2010; 56(1):101-19. PubMed ID: 21328915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution testing of oral modified-release dosage forms.
    Garbacz G; Klein S
    J Pharm Pharmacol; 2012 Jul; 64(7):944-68. PubMed ID: 22686342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the role of gut wall in the fate of orally administered drugs: Why now and to what effect?
    Rostami-Hodjegan A; Tamai I; Pang KS
    Biopharm Drug Dispos; 2017 Mar; 38(2):87-93. PubMed ID: 28317174
    [No Abstract]   [Full Text] [Related]  

  • 13. AC biosusceptometry in the study of drug delivery.
    Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?
    Awasthi R; Kulkarni GT
    Drug Deliv; 2016; 23(2):378-94. PubMed ID: 25026414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of bypass procedures and other anatomical changes in the gastrointestinal tract on the oral bioavailability of drugs.
    De Smet J; Van Bocxlaer J; Boussery K
    J Clin Pharmacol; 2013 Apr; 53(4):361-76. PubMed ID: 23381905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesion and the gastrointestinal tract.
    Varum FJ; McConnell EL; Sousa JJ; Veiga F; Basit AW
    Crit Rev Ther Drug Carrier Syst; 2008; 25(3):207-58. PubMed ID: 18540839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption sites of orally administered drugs in the small intestine.
    Murakami T
    Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiscale absorption and transit model for oral drug delivery: Formulation and applications during fasting conditions.
    Kannan R; Przekwas A
    Int J Numer Method Biomed Eng; 2020 Mar; 36(3):e3317. PubMed ID: 32011090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.